Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1990-09-14
1991-07-30
Elmore, Carolyn
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
564153, C07C23746, A61K 31165, A61K 4904
Patent
active
050358774
ABSTRACT:
Novel non-ionic contrast media are efficiently prepared from generally available ionic contrast media. Particularly, polyhydroxyhalohydrocarbons are employed with a triiodo-substituted acylamido benzoic acids in aqueous weakly basic media to selectively substitute the amido nitrogen, followed by activation of the carboxyl group for amide formation.
REFERENCES:
patent: 3622616 (1971-11-01), Guerbet et al.
patent: 3701771 (1972-10-01), Almen et al.
patent: 3702866 (1972-11-01), Salvesen et al.
patent: 3867431 (1975-02-01), Felder et al.
patent: 4001323 (1977-01-01), Felder et al.
patent: 4021481 (1977-05-01), Almen et al.
patent: 4160015 (1979-07-01), Wiegert
patent: 4250113 (1981-02-01), Nordal et al.
patent: 4341756 (1982-07-01), Sovak et al.
patent: 4364921 (1982-12-01), Speck et al.
patent: 4396597 (1983-08-01), Rakli et al.
patent: 4396598 (1983-08-01), Lin
patent: 4547357 (1985-10-01), Pfeiffer et al.
Havaaveldsen et al., Acta Pharm. Suec. 20, 232, (1983), pp. 219-232.
Ranganathan Ramachandran
Sovak Milos
Cook Imaging Corporation
Elmore Carolyn
LandOfFree
Non-ionic contrast media from ionic contrast media does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-ionic contrast media from ionic contrast media, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-ionic contrast media from ionic contrast media will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1541670